Whether SET increases Rac1 activity to increase migratory capabilities in pancreatic cancer remains unknown; however, it is likely that both SET overexpression and Rac1-induced SET recruitment to the cell surface can concomitantly amplify migratory signals during EMT. This evidence concerns the gene RAC1 and pancreatic neoplasm.